Laerdal Medical and Scanfil have signed a framework agreement for manufacturing at Scanfil’s newly acquired Malaysian factory in Johor Bahru. Scanfil announced an investment of EUR 4.3 million in the factory in January to meet its high customer demand.
“We are very happy that Laerdal Medical has chosen Scanfil and its Malaysian factory as a long-term manufacturing partner for a broad range of products. The agreement proves that our strategy to expand our manufacturing footprint in Southeast Asia is well appreciated by our customers”, says Christian Kesten, Vice President of APAC region at Scanfil. “This partnership reflects the trust Laerdal Medical has placed in our ability to deliver high-quality manufacturing solutions that meet their expectations. We are committed to supporting the Laerdal Group’s mission to improve patient outcomes and save lives through innovative healthcare solutions”.
This collaboration will leverage Scanfil’s expertise in Medtech & Life Science, scalable manufacturing, supply chain management, and operational excellence to ensure the timely delivery of life-saving products to healthcare professionals worldwide. Deliveries will start in mid-2025.
“We are excited about the new agreement. Scanfil has a strong reputation on supply chain management, quality and capability for worldwide deliveries”, state Sjur Gausel, Strategic Sourcing Director at Laerdal Medical. “It also has a long and profound expertise in demanding manufacturing of medical devices, and we see this as the beginning of a long-term partnership”.